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Mother,  Fetus,  and  InfantRavi Mangal Patel, MD, MSc Tracy A. Manuck, MD, MSEditorsBirth is an incredibly exciting and yet potentially dangerous period for a woman and her
fetus, who attempts to navigate the complex transition to neonatal life. Many events
during this period establish or disrupt long-lasting health for both the mother and her
infant. The challenges during this period are too numerous to quantify, but yield oppor-
tunities for prevention and treatment strategies to improve perinatal care and neonatal
outcomes. In this issue of Clinics of Perinatology, we highlight these opportunities by
including articles that span across obstetrics and neonatology. We believe coordi-
nated efforts across the spectrum of care are essential to yield the best possible
outcomes. Toward that goal, Tracy A. Manuck and colleagues’ article, “Quality
Improvement in Perinatal Medicine and Translation of Preterm Birth Research
Findings into Clinical Care,” and Vidya V. Pai and colleagues’ article, “Improving
Uptake of Key Perinatal Interventions Using Statewide Quality Collaboratives,” provide
a context for improving perinatal care, with a focus on quality improvement and coor-
dinated efforts by statewide collaboratives that have had marked success in improving
perinatal care.1 Several topics provide the latest guidance and considerations on the
“personalization” of common perinatal interventions, including the use of antenatal
corticosteroids (See Whitney A. Booker and Cynthia Gyamfi-Bannerman’s article,
“Antenatal Corticosteroids: Who Should We Be Treating?”), methods of delivery (See
Kate F. Walker and Jim G. Thornton’s article, “Delivery at Term: When, How, and
Why”), care of infants with specific birth defects (See Elizabeth K. Sewell and Sarah
Keene’s article, “Perinatal Care of Infants with Congenital Birth Defects”), and coun-
seling at periviable gestational ages (See Matthew A. Rysavy’s article, “Prognosis as
an Intervention”). We also discuss optimization of commonly used or highly effective
neonatal therapies started in the early postnatal period, including therapeutic
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hypothermia (See Girija Natarjan and colleagues’ article, “Therapeutic Hypothermia: 
How Can We Optimize This Therapy to Further Improve Outcomes”), continuous pos-
itive airway pressure (See Clyde J. Wright and colleagues’ article, “Continuous Positive 
Airway Pressure Failure: Evidence-Based and Physiologically Sound Practices from 
Delivery Room to the Neonatal Intensive Care Unit”), caffeine therapy (See Mitali 
Atul Pakvasa and colleagues’ article, “Optimizing Caffeine Use and Risk of 
Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review, Meta-analysis 
and Application of Grading of Recommendations Assessment, Development, and 
Evaluation Methodology”), and oxygen administration (See Vishal Kapadia and Myra 
H. Wyckoff’s article, “Oxygen Therapy in the Delivery Room: What Is the Right 
Dose?”). Our series also touches on perinatal infections, including new threats by 
Zika virus (See Amber M. Wood and Brenna L. Hughes’ article, “Detection and 
Prevention of Perinatal Infection: Cytomegalovirus and ZIKA Virus”) and established 
threats by HIV (See Leilah Zahedi-Spung and Martina L. Badell’s article, “Current 
Strategies to Prevent Maternal-to-Child Transmission of Human Immunodeficiency 
Virus”). The perinatal period also sets in motion critical events shaping an infant’s gut 
and brain health, and two articles review the latest on the maternal-infant microbiome 
(See Gregory Valentine and colleagues’ article, “Relationship Between Perinatal 
Interventions, Maternal-Infant Microbiome and Neonatal Outcomes”) and perinatal 
brain injury (See Christopher M. Novak and colleagues’ article, “Perinatal Brain Injury: 
Mechanisms, Prevention and Outcomes”).
We hope the readers of Clinics in Perinatology find these topics timely and of inter-
est. We would like to thank and acknowledge the contributions of pediatricians, neo-
natologists, obstetricians, and maternal-fetal medicine specialists who have provided 
their expertise to guide perinatal interventions to improve neonatal outcomes.
